Priority Date: 06.09.11 (US 201161531156P)

THE MIRNA-212/132 FAMILY AS A THERAPEUTIC TARGET

  • Application ID: EP12758827
  • Status: The patent has been granted

Attorney

operating since 1882
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 188 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 06.09.2011 - Priority Date (US 201161531156P)
  • 14.03.2013 - Publication A1 (WO2013034653)
  • 16.07.2014 - Publication A1 (EP2753696)
  • 22.11.2017 - Publication B1 (EP2753696)

IPC Classification